SCHEMBL2652725

SCHEMBL2652725

O=C(O)CCNC(=O)c1ccc(OCCc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ FFAR1 O14842 3/20 0.51
▸ FFAR4 Q5NUL3 1/20 0.51
▸ GCGR P47871 4/20 0.50
▸ GIPR P48546 2/20 0.50
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ MAPK14 Q16539 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ PPARA Q07869 4/20 0.48
▸ PPARD Q03181 3/20 0.48
▸ EPHX2 P34913 1/20 0.48
▸ PPARG P37231 1/20 0.47
▸ S1PR1 P21453 1/20 0.47
▸ RHOC P08134 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2652593 0.94 MEN1 (0.57) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2653326 0.94 MEN1 (0.57) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2651906 0.94 MEN1 (0.56) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2655721 0.94 MEN1 (0.56) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2652886 0.93 MEN1 (0.55) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2654122 0.93 MEN1 (0.55) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2653574 0.93 MEN1 (0.55) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2652235 0.93 MEN1 (0.55) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2654985 0.93 MEN1 (0.55) MEN1KMT2AFFAR1FFAR4GCGR
SCHEMBL2653662 0.93 MEN1 (0.55) MEN1KMT2AFFAR1FFAR4GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 — — EP disclosed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 — — WO disclosed
Send feedback